Trending Articles

article thumbnail

CDC eases isolation guidance for Covid and other respiratory illnesses

STAT

The Centers for Disease Control and Prevention is “sunsetting” its advice that people sick with Covid-19 isolate themselves for five days. The agency published new guidance Friday for Covid and other respiratory illnesses, suggesting people who are sick should stay at home until they are fever-free for 24 hours and their symptoms have been improving for the same period of time.

349
349
article thumbnail

Biogen partner NeuroSense seeks a role in the ALS revolution

PharmaVoice

Results from a mid-stage study for a new ALS drug have been strong, and NeuroSense is looking to join a small but sturdy wave of companies bringing new treatments to market.

195
195
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Here are the cancer drugs Pfizer thinks could reignite investors’ interest

STAT

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline. The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed.

article thumbnail

SAEM Clinical Images Series: Neonatal Rash

ALiEM - Pharm Pearls

An 18-day-old male presented for a rash on his face for two days. The patient was born via spontaneous vaginal delivery full term without complications to a mom who has a history of genital HSV but without active lesions at delivery and on acyclovir. The patient presented with a vesicular rash on his face including around his eyes. He had conjunctival discharge noted by mom.

195
195
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Nearly 400,000 vape kits to be sent to smokers

The Pharmacist

Nearly 400,000 vape kits are set to be sent to smokers in England under the government’s swap-to-stop scheme, our sister title Healthcare Leader has exclusively revealed. At least four integrated care boards (ICBs) and more than 80 localities have expressed interest in the scheme with 379,562 ‘vape starter kits’ requested as of February 2024, data […] The post Nearly 400,000 vape kits to be sent to smokers appeared first on The Pharmacist.

125
125
article thumbnail

Viking data suggest obesity drug could rival Zepbound, Wegovy

BioPharma Dive

The biotech’s drug led to significant weight loss in a Phase 2 trial, causing shares to double as analysts compared results to the marks set by drugs from Eli Lilly and Novo Nordisk.

120
120

More Trending

article thumbnail

AstraZeneca’s Voydeya recommended for approval in EU by CHMP

Pharmafile

AstraZeneca has announced that Voydeya (danicopan) has been recommended for marketing authorisation in the European Union (EU) by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA). The drug is a first-in-class oral, Factor D inhibitor developed as an add-on to standard-of-care Ultomiris (ravulizumab) or Soliris (eculizumab) for the […] The post AstraZeneca’s Voydeya recommended for approval in EU by CHMP appeared first on Pharmafile.

110
110
article thumbnail

New film aims to raise awareness of rare disease cALD

pharmaphorum

Rare Disease Day saw the debut of a film that aims to raise awareness of cerebral adrenoleukodystrophy (cALD), a devastating and fatal condition with no pharmacological treatments available.

104
104
article thumbnail

Beacon Therapeutics unveils promising interim results for gene therapy AGTC-501

Pharmaceutical Technology

AGTC-501 is in Phase II development for retinitis in the SKYLINE trial (NCT03316560) and addresses unmet needs within the retinitis space

122
122
article thumbnail

Gritstone to lay off 40% of workforce after costly study delay

BioPharma Dive

The restructuring comes ahead of a key study readout for Gritstone, which, like Moderna, is developing a type of personalized vaccine for cancer.

Vaccines 114
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: Change Healthcare cyber attack outage could persist for weeks, UnitedHealth Group executive suggests

STAT

The outage caused by the Change Healthcare cyberattack could last weeks, a top UnitedHealth executive suggested in a Tuesday conference call with hospital cybersecurity officers, according to a recording obtained by STAT. UnitedHealth Group Chief Operating Officer Dirk McMahon said the company is setting up a loan program to help providers who can’t submit insurance claims while Change is offline.

Hospitals 363
article thumbnail

FDA denial could delay launch of Minerva’s schizophrenia treatment roluperidone by at least two years: GlobalData

Express Pharma

Following the news that the FDA denied approval for Minerva Neurosciences for its roluperidone for the treatment of negative symptoms in patients with schizophrenia; Christie Wong, Neurology Analyst at GlobalData, offers her view: “The FDA has issued a Complete Response Letter (CRL) for Minerva Neurosciences’ roluperidone. It follows a refusal to file in October 2022 and two FDA Type C meetings in November 2020 and March 2022.

105
105
article thumbnail

Seizing the moment: The life sciences industry at the threshold of change

pharmaphorum

Explore the impact of the Inflation Reduction Act (IRA) on drug prices and negotiations within the life sciences industry, as it stands on the threshold of change. Gain insights into the potential outcomes and implications of this legislation.

article thumbnail

Lutris wins FDA orphan drug tag for EGFR inhibitor-induced rash candidate

Pharmaceutical Technology

LUT014 is being investigated in an ongoing Phase II trial as a first-line treatment for EGFR inhibitor-induced acneiform rash, for which there is no approved drug.

104
104
article thumbnail

Obesity drug from Boehringer, Zealand succeeds in MASH trial

BioPharma Dive

Zealand shares rose by more than one-third on the data, which provide further evidence so-called incretin drugs could help treat people with the liver disease.

114
114
article thumbnail

STAT+: A ‘vaccine-like’ version of Wegovy is on the drawing board at Novo Nordisk

STAT

LEXINGTON, Mass. — New obesity drugs like Wegovy and Zepbound are currently taken once a week, indefinitely. But what if they could be taken once a year instead, like a vaccine? That’s a question that Novo Nordisk, the pharma company behind Wegovy, is exploring as it faces increased competition from other drugmakers aiming to develop similar GLP-1-based treatments for obesity.

Vaccines 363
article thumbnail

Baseimmune secures funding for vaccine development

Pharmaceutical Business Review

The investment, led by MSD Global Health Innovation Fund and IQ Capital, with contributions from Hoxton Ventures, Creator Fund, Beast Ventures, and Maki.vc, will expedite the progress of Baseimmune’s technology and vaccine candidates. The capital infusion will accelerate the preclinical development of Baseimmune’s three vaccine candidates targeting African swine fever, coronavirus, and malaria.

Vaccines 105
article thumbnail

Sanofi trumpets win for oral BTK drug in chronic hives

pharmaphorum

Sanofi gets a win for its oral BTK inhibitor rilzabrutinib in chronic hive disorder CSU, setting up a phase 3 programme as it chases after Novartis’ remibrutinib in this indication.

115
115
article thumbnail

APTUK: 'Enabling pharmacy technicians is about patient access'

The Pharmacist

Proposed changes to supervision and patient group directions (PGDs) will deliver increased access to care ‘for the patient’ and relieve pressures on the workforce, the vice president of the Association of Pharmacy Technicians UK (APTUK) has suggested. Nicola Stockmann addressed ‘fearmongering’ around proposed changes to supervision – which the government is accepting feedback on until […] The post APTUK: 'Enabling pharmacy technicians is about patient access' appeared first on Th

article thumbnail

NICE recommends first licenced treatment for AL amyloidosis

European Pharmaceutical Review

Eligible individuals in England and Wales can access the first licensed treatment for amyloid light-chain (AL) amyloidosis on the NHS. The National Institute for Health and Care Excellence (NICE) recommended DARZALEX ® (daratumumab) plus VELCADE ® (bortezomib), cyclophosphamide and dexamethasone (DVCd) as an option for people newly diagnosed with the systemic form of the disease.

article thumbnail

Amid measles outbreaks, U.K. launches vaccination ad campaign to boost childhood immunizations

STAT

LONDON — Facing a growing outbreak of measles, the U.K. has unveiled an advertising campaign aimed at boosting vaccination rates in children, which have steadily fallen over the past decade and took an even greater dip during the height of the Covid-19 pandemic. The campaign, starting March 4, features children talking about their lack of protection from infections like measles and whooping cough if they’re not vaccinated.

Immunity 362
article thumbnail

Researchers reveal COVID-19 could have small impacts on cognition and memory

Pharma Times

Different factors, such as illness duration and virus variant, impacted patients cognitive abilities

119
119
article thumbnail

FDA says yes to Allecra, no to Venatorx UTI drugs

pharmaphorum

The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs) that will now launch later this year, but turned down a rival product from Venatorx.

112
112
article thumbnail

‘A healthy kid dies and there has been no change’: parents’ anger over lack of warnings for blockbuster asthma drug

The Guardian - Pharmaceutical Industry

Teenager Harry Miller took his own life two years after being prescribed montelukast. His family say they were not made aware of the reported psychiatric side-effects of the drug Harry Miller was a popular teenager, appreciated for his sharp humour, ability to get on with anyone and eagerness “for the next adventure”. In the autumn of 2017, he was struggling with difficult thoughts and feelings of anger.

90
article thumbnail

India’s Tata Institute develops tablet for cancer recurrence prevention

Pharmaceutical Technology

India’s Tata Institute has developed a tablet combining resveratrol and copper that has the potential to prevent the recurrence of cancer.

111
111
article thumbnail

More than 1 billion people have obesity, including 159 million young people, study estimates

STAT

More than 1 billion people — or one in eight people worldwide — are now estimated to have obesity, a new study finds. Obesity rates grew particularly fast among children and teens, quadrupling from 1990 to 2022, the latest year the analysis looked at, while rates among adults more than doubled. That comes to 159 million children and teens with obesity, and 879 million adults, according to the study, published Thursday in the Lancet and conducted by the NCD Risk Factor Collaboration

362
362
article thumbnail

Basic cleaning and sanitation practices in Pharmaceuticals

GMPSOP

Basic cleaning and sanitation practices in Pharmaceuticals Pharmaceuticals quality assurance & validation procedures GMPSOP %title% Prev PREVIOUS POST Cleaning and sanitation of pharmaceutical equipment and facilities account for almost one-third of all production activities, if not more. Uncompromised safety and efficacy of pharmaceutical products are the best outcomes for the patients.

article thumbnail

GSK antibiotic gepotidacin clears phase 3 gonorrhoea trial

pharmaphorum

GSK has reported topline results from a phase 3 trial of its novel antibiotic gepotidacin that could spell the end of a decades-long drought in new oral therapies for gonorrhoea.

114
114
article thumbnail

Cost-Cut Without Compromise: Navigating Excipient Switching in Pharma

Drug Patent Watch

Switching pharmaceutical excipients, the inactive components used in drug formulations, can have significant implications for both production costs and market appeal. These components, while not contributing directly to the therapeutic… The post Cost-Cut Without Compromise: Navigating Excipient Switching in Pharma appeared first on DrugPatentWatch - Make Better Decisions.

104
104
article thumbnail

What Your Pharmacy Can Do for National Nutrition Month

Digital Pharmacist

Did you know March is National Nutrition Month ? National Nutrition Month is an annual campaign sponsored by the Academy of Nutrition and Dietetics and it’s a great opportunity for local pharmacies to educate their patients on the importance of good nutrition, healthy diets, and exercise. Springtime, March specifically, is an excellent time of year for you to start conversations with your patients about the various foods they’re eating and how they can enhance their diets to improve

article thumbnail

ICR study reveals new targeted immunotherapy to prevent spread of breast cancer

Pharma Times

Breast cancer is responsible for around 47,000 new cases in England every year

135
135
article thumbnail

Scaling innovation across hospitals and nations

pharmaphorum

Explore how innovation in healthcare can be scaled across hospitals and nations, driving transformation through research & development, biotech collaborations, and fostering start-ups in the industry.

Hospitals 104
article thumbnail

Amgen opens its most advanced manufacturing facility to date

European Pharmaceutical Review

Amgen has opened a new biomanufacturing plant in Central Ohio, US. It is the company ’s most advanced manufacturing facility to date. The new facility, known as Amgen Ohio, “was designed with the latest innovation and technology to deliver safe, reliable medicines for ‘every patient, every time,'” stated Robert Bradway, Chairman and Chief Executive Officer at Amgen. “As part of Amgen’s global biomanufacturing network, Amgen Ohio will play an important role in helping us

article thumbnail

Biogen's Qalsody receives positive opinion from CHMP for ALS treatment in Europe

Outsourcing Pharma

Biogen Inc. has announced a significant advancement in the treatment of amyotrophic lateral sclerosis (ALS), commonly known as motor neuron disease (MND).

105
105
article thumbnail

RSV vaccines may be linked to small increased risk of developing Guillain-Barré syndrome, data suggest

STAT

The new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be linked to a small increased risk of developing Guillain-Barré syndrome, new data from the Centers for Disease Control and Prevention and the Food and Drug Administration suggest. At a meeting Thursday of the Advisory Committee on Immunization Practices, vaccine safety experts from the two agencies presented data that showed what appears to be an elevated rate of GBS, as the condition is called, am

Vaccines 357